These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25665470)

  • 21. Study of genetic and epigenetic alterations in urine samples as diagnostic markers for prostate cancer.
    Dimitriadis E; Kalogeropoulos T; Velaeti S; Sotiriou S; Vassiliou E; Fasoulis L; Klapsas V; Synesiou M; Apostolaki A; Trangas T; Pandis N
    Anticancer Res; 2013 Jan; 33(1):191-7. PubMed ID: 23267145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.
    Minciu R; Dumache R; Gheorghe P; Daminescu L; Rogobete AF; Ionescu D
    Clin Lab; 2016; 62(6):1183-6. PubMed ID: 27468582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
    J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA-based detection of prostate cancer in urine after prostatic massage.
    Goessl C; Müller M; Heicappell R; Krause H; Straub B; Schrader M; Miller K
    Urology; 2001 Sep; 58(3):335-8. PubMed ID: 11549474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Qualitative analysis of Adenomatous Polyposis Coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker.
    Zare M; Jazii FR; Alivand MR; Nasseri NK; Malekzadeh R; Yazdanbod M
    BMC Cancer; 2009 Jan; 9():24. PubMed ID: 19149902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
    Rouprêt M; Hupertan V; Catto JW; Yates DR; Rehman I; Proctor LM; Phillips J; Meuth M; Cussenot O; Hamdy FC
    Int J Cancer; 2008 Feb; 122(4):952-6. PubMed ID: 17960617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene promoter methylation and its potential relevance in early prostate cancer diagnosis.
    Steiner I; Jung K; Schatz P; Horns T; Wittschieber D; Lein M; Dietel M; Erbersdobler A
    Pathobiology; 2010; 77(5):260-6. PubMed ID: 21116117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel.
    Dulaimi E; Uzzo RG; Greenberg RE; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Mar; 10(6):1887-93. PubMed ID: 15041703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma.
    Enokida H; Shiina H; Urakami S; Terashima M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Igawa M; Dahiya R
    Cancer; 2006 Jan; 106(1):79-86. PubMed ID: 16323173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.
    Matuschek C; Bölke E; Lammering G; Gerber PA; Peiper M; Budach W; Taskin H; Prisack HB; Schieren G; Orth K; Bojar H
    Eur J Med Res; 2010; 15(7):277-86. PubMed ID: 20696638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GSTP1 CpG island hypermethylation for DNA-based detection of occult tumor cells in surgical margins after radical prostatectomy.
    Jentzmik F; Krause H; Reichelt U; Schrader AJ; Schrader M; Baumunk D; Cash H; Miller K; Schostak M
    World J Urol; 2012 Aug; 30(4):541-6. PubMed ID: 21947551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer.
    Litovkin K; Van Eynde A; Joniau S; Lerut E; Laenen A; Gevaert T; Gevaert O; Spahn M; Kneitz B; Gramme P; Helleputte T; Isebaert S; Haustermans K; Bollen M
    PLoS One; 2015; 10(6):e0130651. PubMed ID: 26086362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
    Goessl C; Krause H; Müller M; Heicappell R; Schrader M; Sachsinger J; Miller K
    Cancer Res; 2000 Nov; 60(21):5941-5. PubMed ID: 11085508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
    Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D
    Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells.
    Lin X; Tascilar M; Lee WH; Vles WJ; Lee BH; Veeraswamy R; Asgari K; Freije D; van Rees B; Gage WR; Bova GS; Isaacs WB; Brooks JD; DeWeese TL; De Marzo AM; Nelson WG
    Am J Pathol; 2001 Nov; 159(5):1815-26. PubMed ID: 11696442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
    Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
    Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Value of GSTP1, RASSF1, AND RASSF2 Methylation in Serum of Prostate Cancer Patients.
    Aykanli E; Arisan S; Arisan ED; Yavuzsan AH
    Urol J; 2024 May; 21(3):182-188. PubMed ID: 38493315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
    Cairns P; Esteller M; Herman JG; Schoenberg M; Jeronimo C; Sanchez-Cespedes M; Chow NH; Grasso M; Wu L; Westra WB; Sidransky D
    Clin Cancer Res; 2001 Sep; 7(9):2727-30. PubMed ID: 11555585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of glutathione-S-transferases (GST) polymorphisms and hypermethylation of relevant genes on risk of prostate cancer biochemical recurrence: a meta-analysis.
    Chen R; Ren S; Meng T; Aguilar J; Sun Y
    PLoS One; 2013; 8(9):e74775. PubMed ID: 24086370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.